Segment Information - Schedule of Performance Measured Used by CODM (Details) - USD ($) |
3 Months Ended | 9 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|
Sep. 30, 2026 |
Jun. 30, 2026 |
Mar. 31, 2026 |
Sep. 30, 2025 |
Jun. 30, 2025 |
Mar. 31, 2025 |
Sep. 30, 2026 |
Sep. 30, 2025 |
|
| Schedule of Performance Measured Used by CODM [Line Items] | ||||||||
| Total revenue | $ 966,833 | $ 966,833 | ||||||
| Cost of Revenue | 873,243 | 873,243 | ||||||
| Gross Profit | 93,590 | 93,590 | ||||||
| Operating expenses: | ||||||||
| Sales and marketing | 771,150 | 434,827 | 2,511,523 | 2,453,249 | ||||
| Research and development | 1,255,029 | 39,318 | 5,834,350 | 229,344 | ||||
| General and administrative | 2,929,422 | 692,590 | 9,160,832 | 2,859,742 | ||||
| Total operating expenses | 4,955,601 | 1,166,735 | 17,506,705 | 5,542,335 | ||||
| Other income (expense) | (58,158) | (41,299) | (64,969) | (115,141) | ||||
| Loss from discontinued operations | (461,272) | (1,711,312) | (4,001,819) | (5,744,594) | ||||
| Net loss | (5,381,441) | $ (11,016,480) | $ (5,081,982) | (2,919,346) | $ (3,479,833) | $ (5,002,891) | (21,479,903) | (11,402,070) |
| Quantum Drones [Member] | ||||||||
| Schedule of Performance Measured Used by CODM [Line Items] | ||||||||
| Total revenue | 966,833 | 966,833 | ||||||
| Cost of Revenue | 873,243 | 873,243 | ||||||
| Gross Profit | 93,590 | 93,590 | ||||||
| Operating expenses: | ||||||||
| Sales and marketing | 287,422 | 287,422 | ||||||
| Research and development | 669,976 | 5,035,208 | ||||||
| General and administrative | 879,228 | 1,010,683 | ||||||
| Total operating expenses | 1,836,626 | 6,333,313 | ||||||
| Other income (expense) | 16,701 | 16,701 | ||||||
| Loss from discontinued operations | ||||||||
| Net loss | (1,726,335) | (6,223,022) | ||||||
| Genetic Diagnostic [Member] | ||||||||
| Schedule of Performance Measured Used by CODM [Line Items] | ||||||||
| Total revenue | ||||||||
| Cost of Revenue | ||||||||
| Gross Profit | ||||||||
| Operating expenses: | ||||||||
| Sales and marketing | ||||||||
| Research and development | 12,000 | 20,000 | 42,000 | 76,328 | ||||
| General and administrative | 9,263 | 15,279 | 48,942 | 57,382 | ||||
| Total operating expenses | 21,263 | 35,279 | 90,942 | 133,710 | ||||
| Other income (expense) | ||||||||
| Loss from discontinued operations | ||||||||
| Net loss | (21,263) | (35,279) | (90,942) | (133,710) | ||||
| Corporate [Member] | ||||||||
| Schedule of Performance Measured Used by CODM [Line Items] | ||||||||
| Total revenue | ||||||||
| Cost of Revenue | ||||||||
| Gross Profit | ||||||||
| Operating expenses: | ||||||||
| Sales and marketing | 483,728 | 434,827 | 2,224,101 | 2,453,249 | ||||
| Research and development | 573,053 | 19,318 | 757,142 | 153,016 | ||||
| General and administrative | 2,040,931 | 677,311 | 8,101,207 | 2,802,360 | ||||
| Total operating expenses | 3,097,712 | 1,131,456 | 11,082,450 | 5,408,625 | ||||
| Other income (expense) | (74,859) | (41,299) | (81,670) | (115,141) | ||||
| Loss from discontinued operations | (461,272) | (1,711,312) | (4,001,819) | (5,744,594) | ||||
| Net loss | $ (3,633,843) | $ (2,884,067) | $ (15,165,939) | $ (11,268,360) | ||||
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of other research and development expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|